Drug approved in U.S. to combat both stomach and kidney cancer

WASHINGTON (AP) - A new drug that combats both a rare stomach cancer and advanced kidney cancer won speedy federal approval in the United States on Thursday. Sunitinib, to be marketed by Pfizer Inc. as Sutent, is the first cancer drug to simultaneously win U.S....More